title: [Short and long-term therapeutic efficacy of drug-eluting stents (Firebird) for the treatment of coronary artery disease].
abstract: OBJECTIVE
  To evaluate the short and long-term therapeutic efficacy of drug-eluting stents (Firebird) for the treatment of coronary artery disease.
  
  
  METHODS
  From Nov. 2003 to Jan. 2005, 501 Firebird stents were implanted in 410 patients with 460 lesions. All patients were administered with aspirin and clopidogrel before and after the procedures. Follow-up was made by telephone or interview, 102 out of 410 patients were followed up by angiography.
  
  
  RESULTS
  The procedure success rate was 99.5%. Stent thrombosis occurred in one patient during the procedure and one sudden death developed 10 hours after the procedure in hospital. The major adverse cardiac event (MACE, including death, acute myocardial infarction and target lesion revascularization) rate during hospitalization was 0.2% (1/410). The MACE rate was 4.3% (16/376) and the stent thrombosis rate was 1.1% (4/376) during clinical follow-up of 376 patients (12.8 +/- 3.2 months). The angiographic restenosis rate in 102 patients with 122 lesions was 9.8% (12/122).
  
  
  CONCLUSIONS
  Firebird drug-eluting stent could be used safely and effectively in patient with coronary heart disease.
authors.affiliation: Department of Cardiology, Beijing Anzhen Hospital, the Capital University of Medical Sciences, Beijing 100029, China. hejqiang@sina.com
authors.forename: Ji-Qiang
authors.initials: JQ
authors.lastname: He
authors.forename: Zheng
authors.initials: Z
authors.lastname: Li
authors.forename: Yue-Chun
authors.initials: YC
authors.lastname: Gao
authors.forename: Chang-Yan
authors.initials: CY
authors.lastname: Wu
authors.forename: Xiao-Ling
authors.initials: XL
authors.lastname: Zhang
authors.forename: Yu
authors.initials: Y
authors.lastname: Li
authors.forename: Hua
authors.initials: H
authors.lastname: Zhao
authors.forename: Ye
authors.initials: Y
authors.lastname: Wang
authors.forename: Zhi-Hong
authors.initials: ZH
authors.lastname: Han
authors.forename: Wei-Dong
authors.initials: WD
authors.lastname: Zhang
authors.forename: Fang
authors.initials: F
authors.lastname: Chen
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D020123:Sirolimus / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D020123:Sirolimus